Mandadi Tilak has filed 12 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 22277 shares of CVS HEALTH Corp ($CVS) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief Exp & Tech Officer | A | Common Stock (RSUs) | 22277 | $71.82 | 88,543.0000 | 1,271,000,000 | 33.62% | 0.00% |
| March 31, 2026 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief Exp & Tech Officer | A | Stock Option | 143712 | $71.82 | 143,712.0000 | 1,271,000,000 | 9999.99% | 0.01% |
| April 1, 2026 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief Exp & Tech Officer | F | Common Stock | 3634 | $72.49 | 79,684.0000 | 1,271,000,000 | 4.36% | 0.00% |
| Nov. 30, 2025 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief Exp & Tech Officer | F | Common Stock | 6575 | $80.36 | 74,085.0000 | 1,269,000,000 | 8.15% | 0.00% |
| Aug. 31, 2025 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief Exp & Tech Officer | F | Common Stock | 12834 | $73.15 | 63,952.0000 | 1,262,000,000 | 16.71% | 0.00% |
| April 1, 2025 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief Experience & Tech | F | Common Stock | 995 | $67.98 | 43,503.0000 | 1,262,000,000 | 2.24% | 0.00% |
| April 1, 2025 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief Experience & Tech | A | Common Stock (RSU) | 20594 | $67.98 | 116,257.0000 | 1,262,000,000 | 21.53% | 0.00% |
| April 1, 2025 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief Experience & Tech | A | Stock Option | 87336 | $67.98 | 87,336.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| Nov. 30, 2024 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief DDAT Officer | A | Common Stock (RSU) | 50125 | $59.85 | 99,747.0000 | 1,262,000,000 | 101.01% | 0.00% |
| Aug. 31, 2024 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief Technology Officer | F | Common Stock | 13097 | $57.24 | 40,414.0000 | 1,290,000,000 | 24.48% | 0.00% |
| April 1, 2024 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief Technology Officer | A | Stock Option | 67920 | $79.56 | 67,920.0000 | 1,290,000,000 | 9999.99% | 0.01% |
| April 1, 2024 | CVS HEALTH Corp | $CVS | Mandadi Tilak | EVP, Chief Technology Officer | A | Common Stock (RSU) | 16339 | $0.00 | 82,904.0000 | 1,290,000,000 | 24.55% | 0.00% |